NF2 gene in neurofibromatosis type 2 patients

Human Molecular Genetics

Volumn 7, Issue 13, 1998, Pages 2095-2101

  Zucman Rossi, Jessica ^a   Legoix, Patricia ^a   Der Sarkissian, Hera ^b   Cheret, Genevieve ^c   Sor, Frederic ^c   Bernardi, Alberto ^d   Cazes, Lucien ^b   Giraud, Sophie ^e   Ollagnon, Elisabeth ^e   Lenoir, Gilbert ^e   Thomas, Gilles ^a  

^a INSERM   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c CNRS   (France)

^d INSTITUT JACQUES MONOD   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; EZRIN; MOESIN; NERVE PROTEIN; RADIXIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME MOSAICISM; CLINICAL ARTICLE; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC SCREENING; HUMAN; HUMAN CELL; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PENETRANCE; POINT MUTATION; PRIORITY JOURNAL;

EID: 7844235475     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.13.2095     Document Type: Article

References (37)

1. Kanter, W.R., Eldridge, R., Fabricant, R., Allen, J.C. and Koerber, T. (1980) Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology. 30, 851-859.
2. Martuza, R.L. and Eldridge, R. (1988) Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N. Engl. J. Med., 318, 684-688.
3. Kaiser-Kupfer, M.I., Freidlin, V. Datiles, M.B., Edwards, P.A., Sherman, J.L., Parry, D., McCain, L.M. and Eldridge, R. (1989) The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch. Ophthalmol., 107, 541-544.
4. Evans, D.G., Huson, S.M., Donnai, D., Neary, W., Blair, V., Teare, D., Newton, V., Strachan, T., Ramsden, R. and Harris, R. (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J. Med. Genet., 29, 841-846.
5. Maher, E.R., Iselius, L., Yates, J.R., Littler, M., Benjamin, C., Harris, R., Sampson, J., Williams, A., Ferguson-Smith, M.A. and Morton, N. (1991) Von Hippel-Lindau disease: a genetic study. J. Med. Genet., 28, 443-447.
6. Huson, S.M., Compston, D.A., Clark, P. and Harper, P.S. (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J. Med. Genet., 26, 704-711.
7. Wishart, J.H. (1822) Case of tumors in the skull, dura mater, and brain. Edinburgh Med. Surg. J., 18, 393-397.
8. Gardner, W.J. and Frazier, C.H. (1930) Bilateral acoustic neurofibromas: a clinical study and field survey of a family of five generations with bilateral deafness in thirty-eight members. Arch. Neurol. Psychiatry, 23, 266-302.
9. Parry, D.M., Eldridge, R., Kaiser-Kupfer, M.I., Bouzas, E.A., Pikus, A. and Patronas, N. (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am. J. Med. Genet., 52, 450-461.
10. Rouleau, G.A., Wertelecki, W., Haines, J.L., Hobbs, W.J., Trofatter, J.A., Seizinger, B.R., Martuza, R.L., Superneau, D.W., Conneally, P.M. and Gusella, J.F. (1987) Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature, 329, 246-248.
11. Narod, S.A., Parry, D.M., Parboosingh, J., Lenoir, G.M., Ruttledge, M., Fischer, G., Eldridge, R., Martuza, R.L., Frontali, M. and Haines, J. (1992) Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am. J. Hum. Genet., 51, 486-496.
12. Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C. and Plougastel, B. (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature, 363, 515-521.
13. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A.G. and Pulaski, K. (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 75, 826.
14. Deguen, B., Merel, P., Goutebroze, L., Giovannini, M., Reggio, H., Arpin, M. and Thomas, G. (1998) Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane. Hum. Mol. Genet., 7, 217-226.
15. Scoles, D.R., Huynh, D.P., Morcos, P.A., Coulsell, E.R., Robinson, N.G., Tamanoi, F. and Pulst, S.M. (1998) Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin. Nature Genet., 18, 354-359.
16. Gutmann, D.H., Geist, R.T., Xu, H., Kim, J.S. and Saporito-Irwin, S. (1998) Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum. Mol. Genet., 7, 335-345.
17. Bianchi, A.B., Milsunaga, S.I., Cheng, J.Q., Klein, W.M., Jhanwar, S.C., Seizinger, B., Kley, N., Klein-Szanto, A.J. and Testa, J.R. (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl Acad. Sci. USA, 92, 10854-10858.
18. MacCollin, M., Ramesh, V., Jacoby, L.B., Louis, D.N., Rubio, M.P., Pulaski, K., Trofatter, J.A., Short, M.P., Bove, C. and Eldridge, R. (1994) Mutational analysis of patients with neurofibromatosis 2. Am. J. Hum. Genet., 55, 314-320.
19. Merel, P., Khe, H.X., Sanson. M., Bijlsma, E., Rouleau, G., Laurent-Puig, P., Pulst, S., Baser, M., Lenoir, G. and Sterkers, J.M. (1995) Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer, 12, 117-127.
20. Bourn, D., Evans, G., Mason, S., Tekes, S., Trueman, L. and Strachan, T. (1995) Eleven novel mutations in the NF2 tumour suppressor gene. Hum. Genet., 95, 572-574.
21. Ruttledge, M.H., Andermann, A.A., Phelan, C.M., Claudio, J.O., Han, F.Y., Chretien, N., Rangaratnam, S., MacCollin, M., Short, P., Parry, D., Michels, V., Riccardi, V.M., Weksberg, R., Kitamura, K., Bradbum, J.M., Hall, B.D., Propping, P. and Rouleau, G.A. (1996) Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am. J. Hum. Genet., 59, 331-342.
22. Parry, D.M., MacCollin, M.M., Kaiser-Kupfer, M.I., Pulaski, K., Nicholson, H.S., Bolesta, M., Eldridge, R. and Gusella, J.F. (1996) Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am. J. Hum. Genet., 59, 529-539.
23. Watson, C.J., Gaunt, L., Evans, G., Patel, K., Harris, R. and Strachan, T. (1993) A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum. Mol. Genet., 2, 701-704.
24. Sanson, M., Marineau, C., Desmaze, C., Lutchman, M., Ruttledge, M., Baron, C., Narod, S., Delattre, O., Lenoir, G. and Thomas, G. (1993) Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum. Mol Genet., 2, 1215-1220.
25. Arai, E., Ikeuchi, T. and Nakamura, Y. (1994) Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2). Hum. Mol. Genet., 3, 937-939.
26. Jurka, J. and Milosavljevic, A. (1991) Reconstruction and analysis of human Alu genes. J. Mol. Evol., 32, 105-121.
27. Gardiner-Garden, M. and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196, 261-282.
28. Aguinaga, M., Sharan, C., Singh, D.N., Kegler, D., Siddiqui, K.A. and Valenzuela, M.S. (1989) Chromosomal mapping and nucleotide sequence of a human DNA autonomously replicating sequence. Genomics, 5, 605-611.
29. Gutmann, D.H., Geist, R.T., Xu, H.M., Kim, J.S. and Saporito-Irwin, S. (1998) Defects in neurofibromatosis 2 protein function can arise at multiple levels. Hum. Mol. Genet., 7, 335-345.
30. Cnossen, M.H., van der Est, M.N., Breuning, M.H., van Asperen, C.J., Breslau-Siderius, E.J., van der Ploeg, A.T., de Goede-Bolder, A., van den Ouweland, A.M., Halley, D.J. and Niermeijer, M.F. (1997) Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum. Mutat., 9, 458-464.
31. Kayes, L.M., Burke, W., Riccardi, V.M., Bennett, R., Ehrlich, P., Rubenstein, A. and Stephens, K. (1994) Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am. J. Hum. Genet., 54, 424-436.
32. Bijlsma, E.K., Wallace, A.J. and Evans, D.G. (1997) Misleading linkage results in an NF2 presymptomatic test owing to mosaicism. J. Med. Genet., 34, 934-936.
33. Zucman-Rossi, J., Legoix, P. and Thomas, G. (1996) Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region. Genomics, 38, 247-254.
34. Zucman, J., Delattre, O., Desmaze, C., Plougastel, B., Jouhert, I., Melot, T., Peter, M., De Jong, P., Rouleau, G. and Aurias, A. (1992) Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer, 5, 271-277.
35. Deguen, B., Goutebroze, L., Giovannini, M., Boisson, C., Von Der Neut, R., Jourand, M.C. and Thomas, G. (1998) Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene. Int. J. Cancer, in press.
36. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G. and Lathrop, M. (1992) A second-generation linkage map of the human genome. Nature, 359, 794-801.
37. Cherif, D., Bernard, O. and Berger, R. (1989) Detection of single-copy genes by nonisotopic in situ hybridization on human chromosomes. Hum. Genet., 81, 358-362.